论文部分内容阅读
本组织曾于1983年报道过“世界卫生组织欧洲多因子预防冠心病协作试验”的发病率和死亡率的部分结果。其间报道的分析仅考虑了干预组和对照组之间的总体差异,以试观使冠心病危险因子团体改变后有何效果。在比利时试验中心,冠心病(CHD)总发病率下降24%,显著性水平为5%。在罗马和克拉科夫试验中心,因工厂较少,类似的下降均未达到显著性水平。联合王国(UK)试验中心阳性结果的缺乏使总体得益降至不显著水平。在降低危险因子水平方面,UK 试验中心的成效最少,以致其结果毫不惊人。
The organization had reported in 1983 the partial results of the morbidity and mortality of the WHO Multifactorial Prevention of Coronary Heart Disease Collaborative Trial in Europe. The analysis reported during this period only considered the overall difference between the intervention group and the control group to see what effect the coronary heart disease risk factor group changes after trying. The total incidence of coronary heart disease (CHD) decreased by 24% at the Belgium Experimental Center, with a significance level of 5%. In Rome and Krakow test centers, similar declines did not reach the level of significance due to fewer factories. The lack of positive results from the United Kingdom (UK) test center reduced overall benefits to insignificant levels. In terms of reducing the risk factor level, the UK test center has achieved the least amount of results, and the result is not surprising.